News
Independent Survey Highlights Leading Vendors Driving Innovation in Managed Care IT Ahead of the AHIP 2025 Conference in Las ...
DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT - CUSIP: 23306J309) ...
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- ...
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / On June 11, 2025, Aduro Clean Technologies Inc. ("Aduro" or the "Company") (Nasdaq:ADUR)(CSE:ACT)(FSE:9D5), a clean technology company using the p ...
SAN FRANCISCO, CA / ACCESS Newswire / June 12, 2025 / At Good Driver Mutuality (GDM), we begin by understanding the unique challenges responsible drivers face in stressful moments, and we deliver prac ...
The 5.5-year collaboration will bring elite sports science, hydration expertise, and global visibility to the next generation of female F1 drivers. Gatorade® becomes the first-ever official ...
New availability as part of NVIDIA AI Enterprise expands access to high-performance, secure LLMs for private deployment TEL AVIV, ISRAEL / ACCESS Newswire / June 12, 2025 / AI21 today announced that i ...
NEWPORT BEACH, CA / ACCESS Newswire / June 12, 2025 / Amaze Holdings, Inc. (NYSE American:AMZE) ("Amaze" or the "Company"),a global leader in creator-powered commerce, today announced the results of i ...
Health Plans and Payers Align Around VBRO Technology to Meet CMS Payment Reform Demands; Top-Rated Vendors Identified for Impactful Results LAS VEGAS, NV / ACCESS Newswire / June 12, 2025 / In prepara ...
HIGHLAND HEIGHTS, KY / ACCESS Newswire / June 12, 2025 / Prysmian, a world leader in the energy transition and digital transformation, announced today that Christina Trainor has returned to the organi ...
Originally published on DICK'S Sporting Goods Sideline Report NORTHAMPTON, MA / ACCESS Newswire / June 12, 2025 / June 11 marked a historic first for DICK'S Sporting Goods and The DICK'S Sporting Good ...
Novo Nordisk today announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight management based on completed clinical studies. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results